Stand Up To Cancer (SU2C), a LA-based cancer research nonprofit, has been at the forefront of cutting-edge cancer research for over 15 years, working to connect the top minds in science to address this global health issue. SU2C-funded research has contributed to major breakthroughs, including the first successful demonstration
of an mRNA vaccine for cancer treatment; the first CAR T-cell therapy for widespread use; and an FDA approval for the use of an immunotherapy as a first-line treatment for patients with a certain type of colorectal cancer (one of the major cancer types baffling the scientific community due to a current near doubling of cases in patients under 55).
SU2C has raised nearly $800 million to accelerate the pace of breakthrough cancer research, investing in the most promising ideas that will get treatments to patients quickly. Through SU2C funding, cutting-edge research from over 3,000 scientists at more than 210 leading institutions across 13 countries has impacted hundreds of thousands of people, including patients, their families, caregivers and advocates – insights from that research can now be leveraged to help save thousands more.
An integral part of SU2C’s ability to fundraise is its relationship with the entertainment community. Co-founded by nine female executives from the entertainment and media industries, the organization has worked with over 1,100 celebrity ambassadors to support awareness and fundraising efforts including SU2C’s marquee biennial “roadblock‚” fundraising telecasts and produce nearly 100 PSA campaigns, bringing much-needed attention to cancer research, clinical trials, cancer screenings and more.
